These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 657280)

  • 21. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. II. Inhibition by inhibitors of protein synthesis.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Jul; 38(2):264-75. PubMed ID: 209901
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical criteria for activated macrophages.
    Karnovsky ML; Lazdins JK
    J Immunol; 1978 Sep; 121(3):809-13. PubMed ID: 357654
    [No Abstract]   [Full Text] [Related]  

  • 23. The destruction of tumor cells by alloimmune peritoneal cells: mechanism of action of activated macrophages in vitro.
    Boyle MD; Ormerod MG
    J Reticuloendothel Soc; 1975 Feb; 17(2):73-83. PubMed ID: 804549
    [No Abstract]   [Full Text] [Related]  

  • 24. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytotoxic effect of peritoneal macrophages on an intestinal carcinoma in rats. Demonstration of a new cytotoxicity test].
    Lagneau A; Martin M; Martin F; Michel MF
    C R Seances Soc Biol Fil; 1977; 171(1):90-3. PubMed ID: 143333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
    Piessens WF; Churchill WH; David
    J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between macrophage cultures infected with Trypanosoma dionisii, lymphocytes and macrophages.
    Baker JR; Green SM
    Trans R Soc Trop Med Hyg; 1973; 67(2):265-6. PubMed ID: 4784075
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of the principal cell type yielding immune RNA capable of transferring tumor-specific cellular cytotoxicity.
    Wang BS; Onikul SR; Mannick JA
    Cell Immunol; 1978 Aug; 39(1):27-35. PubMed ID: 699059
    [No Abstract]   [Full Text] [Related]  

  • 29. Macrophage activation: dissociation of cytotoxic activity from Ia-A antigen expression.
    Blumenthal EJ; Roberts WK; Vasil A; Talmage DW
    Proc Natl Acad Sci U S A; 1983 Apr; 80(7):2031-5. PubMed ID: 6572960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated macrophages release a factor which lyses malignant cells but not normal cells.
    Currie GA; Basham C
    J Exp Med; 1975 Dec; 142(6):1600-5. PubMed ID: 1194858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphokines--the mediators of cellular immunity.
    Granger GA
    Ser Haematol; 1972; 5(4):8-40. PubMed ID: 4598038
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of endotoxin in eliciting agents on the activation of mouse macrophages for tumor cell killing.
    Pace JL; Taffet SM; Russell SW
    J Reticuloendothel Soc; 1981 Jul; 30(1):15-21. PubMed ID: 7021820
    [No Abstract]   [Full Text] [Related]  

  • 33. Direct tumor cell and antibody-dependent cell-mediated cytotoxicity by macrophages form germfree and conventional rats.
    Johnson WJ; Balish E
    J Reticuloendothel Soc; 1981 Mar; 29(3):205-14. PubMed ID: 7218232
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.
    Biondi A; Peri G; Colombo N; Bolis G; Mantovani A
    Clin Exp Immunol; 1982 Sep; 49(3):701-8. PubMed ID: 7172502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.
    Meltzer MS; Oppenheim JJ
    J Immunol; 1977 Jan; 118(1):77-82. PubMed ID: 137265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCG-activated macrophages: comparison as effectors in direct tumor-cell cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Adams DO; Koren HS
    Adv Exp Med Biol; 1979; 121B():195-201. PubMed ID: 397747
    [No Abstract]   [Full Text] [Related]  

  • 38. Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.
    Hibbs JB
    J Natl Cancer Inst; 1974 Nov; 53(5):1487-92. PubMed ID: 4473563
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody-dependent peritoneal-cell-mediated cytotoxicity in man.
    Podleski WK; Podleski UG
    Lancet; 1973 Jun; 1(7816):1389. PubMed ID: 4122776
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of selective nonspecific cell-mediated cytotoxicity of virus-infected cells.
    Rager-Zisman B; Grose C; Bloom BR
    Nature; 1976 Mar; 260(5549):369-70. PubMed ID: 176600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.